Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX gene

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 4, 2008, Pages 1386-1389

  Makras, Polyzois ^a   Hamdy, Neveen A T ^a   Kant, Sarina G ^a   Papapoulos, Socrates E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; GROWTH RETARDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALE; MUSCLE DISEASE; MYOPATHY; PATHOPHYSIOLOGY; PHEX GENE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RICKETS; X LINKED HYPOPHOSPHATEMIC RICKETS;

EID: 42049117588     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1296     Document Type: Article

References (20)

1. Whyte MP, Schranck FW, Armamento-Villareal R 1996 X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81:4075-4080
2. Baroncelli GI, Bertelloni S, Sodini F, Galli L, Vanacore T, Fiore L, Saggese G 2004 Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets. Pediatr Endocrinol Rev 1:361-379
3. Goji K, Ozaki K, Sadewa AH, Nishio H, Matsuo M 2006 Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait. J Clin Endocrinol Metab 91:365-370
4. Dixon PH, Christie PT, Wooding C, Trump D, Grieff M, Holm I, Gertner JM, Schmidtke J, Shah B, Shaw N, Smith C, Tau C, Schlessinger D, Whyte MP, Thakker RV 1998 Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab 83:3615-3623
5. Glorieux FH, Karsenty G, Thakker RV 1997 Metabolic bone disease in children. In: Avioli LV, Krane SM, eds. Metabolic bone diseases and clinically related disorders. 3rd ed. New York: Academic Press; 759-783
6. Sochett E, Doria AS, Henriques F, Kooh SW, Daneman A, Makitie O 2004 Growth and metabolic control during puberty in girls with X-linked hypophosphataemic rickets. Horm Res 61:252-256
7. Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E 2003 Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591-3597
8. Hanna JD, Niimi K, Chan JC 1991 X-linked hypophosphatemia. Genetic and clinical correlates. Am J Dis Child 145:865-870
9. de Wijn JF, de Haas JH 1960 Groeidiagrammen van 1-25 jarigen in Nederland. Leiden: N.V. Drukkerij v/h Batteljee, Terpstra
10. Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO 2001 Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3889-3899
11. Econs MJ, Friedman NE, Rowe PS, Speer MC, Francis F, Strom TM, Oudet C, Smith JA, Ninomiya JT, Lee BE, Bergen H 1998 A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 83:3459-3462
12. Filisetti D, Ostermann G, von Bredow M, Strom T, Filler G, Ehrich J, Pannetier S, Garnier JM, Rowe P, Francis F, Julienne A, Hanauer A, Econs MJ, Oudet C 1999 Non-random distribution of mutations in the PHEX gene, and underdetected missense mutations at non-conserved residues. Eur J Hum Genet 7:615-619
13. Glorieux FH 1996 Hypophosphatemic vitamin D-resistant rickets. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd ed. New York: Lipincott-Raven; 316-325
14. Saggese G, Baroncelli GI, Bertelloni S, Perri G 1995 Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. J Pediatr 127:395-402
15. Ariceta G, Langman CB 2007 Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166:303-309
16. Kruse K, Hinkel GK, Griefahn B 1998 Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr 157:894-900
17. Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP 1992 X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583-597
18. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G 2001 Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138:236-243
19. Balsan S, Tieder M 1990 Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J Pediatr 116:365-371
20. Baroncelli GI, Bertelloni S, Perri G, Saggese G 1995 Association between X-linked hypophosphatemic rickets and Klinefelter's syndrome: effects on growth and body proportion. Hum Genet 95:581-585